The Top Line cover image

Misconduct and the future of neurodegenerative disease research

The Top Line

00:00

Investigating Misconduct in Alzheimer's Research

This chapter explores the investigative efforts regarding alleged misconduct linked to Cassava Sciences and its Alzheimer's drug, Simufalam. It highlights the integrity concerns that arose from the data and the broader implications for patients in clinical trials, pointing to a significant crisis in neurodegenerative disease research.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app